Results 231 to 240 of about 44,692 (253)
Some of the next articles are maybe not open access.
[Molecular design of anti-MRSA drugs].
Nihon rinsho. Japanese journal of clinical medicine, 1997The true nature of resistance of methicillin-resistant Staphylococcus aureus (MRSA) is penicillin-binding protein 2' (PBP2'). Affinities of almost all beta-lactam antibiotics to PBP2' were very low. Therefore, MRSA which produces PBP2' shows resistance to all beta-lactam antibiotics.
openaire +1 more source
[Advances in the study of anti-MRSA natural products].
Yao xue xue bao = Acta pharmaceutica Sinica, 2018Methicillin-resistant Staphylococcus aureus (MRSA) is a multi-drug resistant pathogenic bacteria, which has seriously threatened human health for a long time. Discovery of novel anti-MRSA lead compounds with high efficiency and low toxicity represents an important research focus in the realm of antibiotic studies.
Hao, Song, Yong, Qin
openaire +1 more source
Purification and Characterization of Novel Anti-MRSA Peptides Produced by Brevibacillus sp. SPR-20
Molecules, 2022Nuttapon Songnaka +2 more
exaly
Anti-MRSA cephalosporins Bristol-Myers Squibb.
Current opinion in investigational drugs (London, England : 2000), 2002BMS is investigating a series of cephalosporins for potential use in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infection [274213]. In vitro activity tests resulted in a minimum inhibitory concentration (MIC) of 1 to 8 microg/ml against MRSA 1274213].
openaire +1 more source